Maxx Orthopedics' PCK Revision TKA Study of Component Survivorship

NCT03312088 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-07-15

No results posted yet for this study

Summary

The objectives of this clinical investigation are to evaluate the safety and performance of the Freedom Total Knee® PCK System.

Conditions

  • Aseptic Loosening
  • Infection
  • Bone Loss
  • MCL - Medial Collateral Ligament Rupture of the Knee
  • Periprosthetic Fractures

Interventions

DEVICE

Freedom Knee PCK Components

Total Knee Revision

Sponsors & Collaborators

  • Maxx Orthopedics Inc

    lead INDUSTRY

Principal Investigators

  • David Cashin, MD · Coastal Orthopedics

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-01-01
Completion
2022-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03312088 on ClinicalTrials.gov